Melanoma Institute Australia, Sydney, NSW, Australia.
J Surg Oncol. 2014 Mar;109(4):352-6. doi: 10.1002/jso.23540. Epub 2013 Dec 24.
To describe the technique of isolated limb infusion (ILI) for regional high dose chemotherapy in patients with advanced malignancies confined to a limb, as currently practiced at Melanoma Institute Australia (MIA).
ILI is progressively being used around the world but to date the reported response rates are generally lower than those reported by MIA.
This description of the ILI protocol at MIA provides details that may allow other surgeons to improve results.
描述在局限于肢体的晚期恶性肿瘤患者中进行局部高剂量化疗的孤立肢体灌注(ILI)技术,目前在澳大利亚黑色素瘤研究所(MIA)实施。
ILI 在全球范围内的应用正在逐渐增多,但迄今为止,报告的缓解率普遍低于 MIA 报告的缓解率。
MIA 的 ILI 方案描述提供了可能使其他外科医生改善结果的详细信息。